AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Met G 1mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Shalman Pharma Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Met G 1mg/500mg Tablet ER

This extended-release tablet, containing 1mg of one medication and 500mg of another, is classified as an antidiabetic agent. It's a dual-action formulation for managing type 2 diabetes in adults, effectively regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled glucose levels; premature discontinuation, without medical consultation, risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is only one component of a comprehensive diabetes management plan, encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Learn to recognize and manage these symptoms; maintain consistent mealtimes and carry a fast-acting sugar source. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions necessitate informing your physician before commencing treatment. Its suitability for pregnant or breastfeeding individuals requires medical evaluation. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Met G 1mg/500mg Tablet ER

Managing type 2 diabetes

Major Benefits of Met G 1mg/500mg Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or breaking it. The Met G 1mg/500mg Extended-Release tablet should be taken with a meal.

Common Side effects of Met G 1mg/500mg Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Met G 1mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Met G 1mg/500mg Extended-Release tablet whole; do not alter its form by chewing, crushing, or breaking. Administer this medication with food.

How Met G 1mg/500mg Tablet ER works:

Each Met G 1mg/500mg Extended-Release tablet combines glimepiride, a sulfonylurea, and metformin, a biguanide, to manage blood sugar. Glimepiride stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin acts on multiple fronts: decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Met G 1mg/500mg Extended-Release tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Met G 1mg/500mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against these risks prior to prescription. Seek medical advice before using this medication.

Breast feedingBreast feedingUNSAFE

Extended-release Met G 1mg/500mg tablets are contraindicated during lactation. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Met G 1mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. This medication is contraindicated in individuals with severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Met G 1mg/500mg Extended-Release tablets to individuals with hepatic impairment. Dosage modification of Met G 1mg/500mg Extended-Release tablets may be necessary. Physician consultation is advised. Initiate therapy with a reduced Met G 1mg/500mg Extended-Release tablet dose in patients exhibiting mild to moderate liver dysfunction; avoid use in those with severe hepatic disease.

What if you forget to take Met G 1mg/500mg Tablet ER :

Should you forget a dose of your Met G 1mg/500mg Extended-Release tablet, take it promptly. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Met G 1mg/500mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Met G 1mg/500mg Tablet ER

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Metformin (Met G 1mg/500mg Tablet ER) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA). This rare but dangerous side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these symptoms, discontinue Met G 1mg/500mg Tablet ER and seek immediate medical attention.
Met G 1mg/500mg Extended-Release Tablets combine glimepiride and metformin to manage type 2 diabetes. This medication helps control blood sugar in adults when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Met G 1mg/500mg Tablet ER may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Met G 1mg/500mg Tablet ER can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Metformin ER 1mg/500mg can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Met G 1mg/500mg ER tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Met G 1mg/500mg Tablet ER
57
MRP 70
18% off